The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice

REFERENCES

• Schwartz LB, Austen KF, et al: Enzymes of the mast cell granule. J Invest Dermatol. 1980;74:349–353.
   PubMed Web of Science ®Google Scholar
• Welle M, et al: Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol. 1997;61:233–245.
   PubMed Web of Science ®Google Scholar
• Takai S, et al.: A novel chymase inhibitor, 4-[1-([bis-(4-methyl-phenyl)-methyl]-carbamoyl)3-(2-ethoxy-benzyl)-4-oxo-a zetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters. J Pharmacol Exp Ther. 2003;305:17–23.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, : Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure. Circulation. 2003;107:2555–2558.
   PubMed Web of Science ®Google Scholar
• Takai S, : A single treatment with a specific chymase inhibitor, TY-51184, prevents vascular proliferation in canine grafted veins. J Pharmacol Sci. 2004. 94:443–448.
   PubMed Web of Science ®Google Scholar
• Takai S, Miyazaki M, et al: Effect of chymase inhibitor on vascular proliferation. Jpn J Pharmacol. 2002;90:223–227.
   PubMedGoogle Scholar
• Shiota N, : Effect of mast cell chymase inhibitor on the development of scleroderma in tight-skin mice. Br J Pharmacol. 2005;145:424–431.
   PubMed Web of Science ®Google Scholar
• Watanabe N, : Chymase inhibitor improves dermatitis in NC/Nga mice. Int Arch Allergy Immunol. 2002;128:229–234.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, : A specific chymase inhibitor, NK3201, suppresses bleomycin-induced pulmonary fibrosis in hamsters. Eur J Pharmacol. 2004;493:173–176.
   PubMed Web of Science ®Google Scholar
• Tomimori Y, : Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice. Eur J Pharmacol. 2003;478:179–185.
   PubMed Web of Science ®Google Scholar
• Balcells E, : Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol. 1997;273:H1769–1774.
   Web of Science ®Google Scholar
• Miyazaki M, : Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Pharmacol Ther. 2006;112:668–676.
   PubMed Web of Science ®Google Scholar
• Sukenaga Y, : Development of the chymase inhibitor as an anti-tissue-remodeling drug: myocardial infarction and some other possibilities. Jpn J Pharmacol. 2002;90:218–222.
   PubMedGoogle Scholar
• Palaniyandi SS, : Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats. Exp Biol Med (Maywood). 2007;232:1213–1221.
   PubMed Web of Science ®Google Scholar
• He S, Walls AF, et al: Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol. 1998;125:1491–1500.
   PubMed Web of Science ®Google Scholar
• Takai S, : Chymase inhibition provides pancreatic islet protection in hamsters with streptozotocin-induced diabetes. J Pharmacol Sci. 2009;110:459–465.
   PubMed Web of Science ®Google Scholar
• Tashiro K, : Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet. Hepatol Res. 2010;40:514–523.
   PubMed Web of Science ®Google Scholar
• Komeda K, : Chymase inhibition attenuates tetrachloride- induced liver fibrosis in hamsters. Hepatol Res. 2010;40: 832–840.
   PubMed Web of Science ®Google Scholar
• Kakimoto K, : Significance of chymase-dependent matrix metalloproteinase-9 activation on indomethacin-induced small intestinal damages in rats. J Pharmacol Exp Ther. 2010;332:684–689.
   PubMed Web of Science ®Google Scholar
• Ashcroft T, Simpson JM, Timbrell V, et al: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988;41:467–470.
   PubMed Web of Science ®Google Scholar
• Schrier DJ, Phan SH, McGarry BM, et al: The effects of the nude (nu/nu) mutation on bleomycin-induced pulmonary fibrosis. A biochemical evaluation. Am Rev Respir Dis. 1983;127:614–617.
   PubMed Web of Science ®Google Scholar
• Wang X, : Silencing CD36 gene expression results in the inhibition of latent-TGF-beta1 activation and suppression of silica-induced lung fibrosis in the rat. Respir Res. 2009;10:36.
   PubMedGoogle Scholar
• Tchougounova E, Pejler G, Abrink M, et al: The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover. J Exp Med. 2003;198:423–431.
   PubMed Web of Science ®Google Scholar
• Tani K, : Chymase is a potent chemoattractant for human monocytes and neutrophils. J Leukoc Biol. 2000;67:585–589.
   PubMed Web of Science ®Google Scholar
• Terakawa M, : Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils. Eur J Pharmacol. 2006;538:175–181.
   PubMed Web of Science ®Google Scholar
• Nakao A, : Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest. 1999;104:5–11.
   PubMed Web of Science ®Google Scholar
• Hirata K, : Enhanced mast cell chymase expression in human idiopathic interstitial pneumonia. Int J Mol Med. 2007;19:565–570.
   PubMed Web of Science ®Google Scholar
• Mitani Y, : Mast cell chymase in pulmonary hypertension. Thorax. 1999;54:88–90.
   PubMed Web of Science ®Google Scholar
• Pesci A, : Mast cells in fibrotic lung disorders. Chest. 1993;103:989–996.
   PubMed Web of Science ®Google Scholar
• Gersch C, : Mast cells and macrophages in normal C57/BL/6 mice. Histochem Cell Biol. 2002;118:41–49.
   PubMed Web of Science ®Google Scholar
• Suzuki N, : Mast cells are essential for the full development of silica-induced pulmonary inflammation: a study with mast cell-deficient mice. Am J Respir Cell Mol Biol. 1993;9:475–483.
   PubMed Web of Science ®Google Scholar
• He S, Walls AF, et al: The induction of a prolonged increase in microvascular permeability by human mast cell chymase. Eur J Pharmacol. 1998;352:91–98.
   PubMed Web of Science ®Google Scholar
• Adamson IY, Prieditis H, Bowden DH, et al: Instillation of chemotactic factor to silica-injected lungs lowers interstitial particle content and reduces pulmonary fibrosis. Am J Pathol. 1992;141:319–326.
   PubMed Web of Science ®Google Scholar
• Adamson IY, Prieditis H, Bowden DH, et al: Enhanced clearance of silica from mouse lung after instillation of a leukocyte chemotactic factor. Exp Lung Res. 1994;20:223–233.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Takai S, Miyazaki M, et al: Effect of chymase-dependent transforming growth factor beta on peritoneal adhesion formation in a rat model. Surg Today. 2004;34:865–867.
   PubMed Web of Science ®Google Scholar